BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, De Waard M, Al-Hamash SM, Jean-Marc S, Negm WA, Batiha GE. The role of berberine in Covid-19: potential adjunct therapy. Inflammopharmacology 2022. [PMID: 36183284 DOI: 10.1007/s10787-022-01080-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Al-Kuraishy HM, Batiha GE, Al-Gareeb AI, Al-Harcan NAH, Welson NN. Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon. Mol Cell Biochem 2023;:1-9. [PMID: 36652045 DOI: 10.1007/s11010-023-04658-7] [Reference Citation Analysis]
2 Sharma D, Sharma N, Manchanda N, Prasad SK, Sharma PC, Thakur VK, Rahman MM, Dhobi M. Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight. Biomolecules 2022;13. [PMID: 36671402 DOI: 10.3390/biom13010017] [Reference Citation Analysis]
3 Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Youssef FS, El-Sherbeni SA, Negm WA. A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection. Inflammopharmacology 2022;:1-11. [PMID: 36484974 DOI: 10.1007/s10787-022-01111-x] [Reference Citation Analysis]
4 Al-kuraishy HM, Al-gareeb AI, Albogami SM, Jean-marc S, Nadwa EH, Hafiz AA, A. Negm W, Kamal M, Al-jouboury M, Elekhnawy E, Batiha GE, Waard MD. Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19. Pharmaceuticals 2022;15:1361. [DOI: 10.3390/ph15111361] [Reference Citation Analysis]